200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 170861-63-9

170861-63-9

170861-63-9 | 4-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]isoxazolidine-3,5-dione

CAS No: 170861-63-9 Catalog No: AG00BA0Z MDL No:

Product Description

Catalog Number:
AG00BA0Z
Chemical Name:
4-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]isoxazolidine-3,5-dione
CAS Number:
170861-63-9
IUPAC Name:
4-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1,2-oxazolidine-3,5-dione
InChI:
InChI=1S/C22H20N2O5/c1-14-19(23-21(28-14)16-5-3-2-4-6-16)11-12-27-17-9-7-15(8-10-17)13-18-20(25)24-29-22(18)26/h2-10,18H,11-13H2,1H3,(H,24,25)
InChI Key:
QBQLYIISSRXYKL-UHFFFAOYSA-N

Properties

Complexity:
572  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
392.137g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
392.411g/mol
Monoisotopic Mass:
392.137g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
90.7A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
4  

Literature

Title Journal
[Design, synthesis and insulin-sensitizing activity of some peroxisome proliferator-activated gamma agonists]. Yao xue xue bao = Acta pharmaceutica Sinica 20050201
Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARalpha selective activators. Bioorganic & medicinal chemistry letters 20040705
[Chemical structures and pharmacological characteristics of novel non-thiazolidinedione insulin sensitizer (JTT-501, FK614)]. Nihon rinsho. Japanese journal of clinical medicine 20020901
[The chemical structure and pharmacological properties of a novel isoxazolidinedione insulin sensitizer, JTT-501]. Nihon rinsho. Japanese journal of clinical medicine 20011101
Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse. European journal of endocrinology 20010701
Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. European journal of pharmacology 20010629
The PPARs: from orphan receptors to drug discovery. Journal of medicinal chemistry 20000224
Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative. European journal of pharmacology 19990108

Related Products

© 2019 Angene International Limited. All rights Reserved.